Literature DB >> 15936324

Effects of fenofibrate on inflammatory cytokines and blood pressure in patients with hypertriglyceridemia.

Ping Ye, Jian-Jun Li, Gong Su, Cheng Zhang.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15936324     DOI: 10.1016/j.cccn.2005.01.023

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


× No keyword cloud information.
  7 in total

Review 1.  Fenofibrate: a review of its use in primary dyslipidaemia, the metabolic syndrome and type 2 diabetes mellitus.

Authors:  Gillian M Keating; Katherine F Croom
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 2.  Nuclear receptors and inflammatory diseases.

Authors:  Kun Wang; Yu-Jui Yvonne Wan
Journal:  Exp Biol Med (Maywood)       Date:  2008-03-28

Review 3.  Fenofibrate: a review of its use in dyslipidaemia.

Authors:  Kate McKeage; Gillian M Keating
Journal:  Drugs       Date:  2011-10-01       Impact factor: 9.546

4.  Fenofibrate Attenuates Neutrophilic Inflammation in Airway Epithelia: Potential Drug Repurposing for Cystic Fibrosis.

Authors:  Amanda J Stolarz; Ryan A Farris; Charla A Wiley; Catherine E O'Brien; Elvin T Price
Journal:  Clin Transl Sci       Date:  2015-08-10       Impact factor: 4.689

5.  PPARs: Key Regulators of Airway Inflammation and Potential Therapeutic Targets in Asthma.

Authors:  Asoka Banno; Aravind T Reddy; Sowmya P Lakshmi; Raju C Reddy
Journal:  Nucl Receptor Res       Date:  2017-12-11

6.  Fenofibrate reduces C-reactive protein levels in hypertriglyceridemic patients with high risks for cardiovascular diseases.

Authors:  Yun Joo Min; Young Hwan Choi; Cheol Won Hyeon; Jun Hwan Cho; Kyung Joon Kim; Jee Eun Kwon; Eun Young Kim; Wang-Soo Lee; Kwang Je Lee; Sang-Wook Kim; Tae Ho Kim; Chee Jeong Kim
Journal:  Korean Circ J       Date:  2012-11-28       Impact factor: 3.243

7.  The effect of bezafibrate and omega-3 fatty acids on lymphocyte cytokine release and systemic inflammation in patients with isolated hypertriglyceridemia.

Authors:  Robert Krysiak; Anna Gdula-Dymek; Boguslaw Okopien
Journal:  Eur J Clin Pharmacol       Date:  2011-06-01       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.